scholarly journals Efficacy and safety of oral sildenafil citrate (Viagra®) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter, placebo-controlled study

2002 ◽  
Vol 14 (S2) ◽  
pp. S42-S47 ◽  
Author(s):  
F Gómez ◽  
◽  
H Davila ◽  
A Costa ◽  
A Acuña ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Sildenafil Citrate ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Male Erectile Dysfunction

Sustained Efficacy and Safety of Vardenafil for Treatment of Erectile Dysfunction: A Randomized, Double-Blind, Placebo-Controlled Study

2005 ◽  
Vol 80 (10) ◽  
pp. 1291-1297 ◽  
Author(s):  
Luc Valiquette ◽  
Jay M. Young ◽  
Ignacio Moncada ◽  
Hartmut Porst ◽  
Jean-Guy Vézina ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Controlled Study ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Sustained Efficacy

scholarly journals Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

2001 ◽  
Vol 178 (4) ◽  
pp. 325-330 ◽  
Author(s):  
Ian Eardley ◽  
Robert Morgan ◽  
Wallace Dinsmore ◽  
Paula Yates ◽  
Mitradev Boolell
Keyword(s):  
Erectile Dysfunction ◽  
Crossover Study ◽  
Sexual Satisfaction ◽  
Day Treatment ◽  
Sildenafil Citrate ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Frequency Of Use ◽  
The Uk ◽  
Flexible Dose

BackgroundErectile dysfunction is a common, multi-factorial disorder.AimsTo evaluate the efficacy, tolerability and frequency of use of sildenafil citrate in men with mild to moderate erectile dysfunction of no established organic cause.MethodThis double-blind, randomised, placebo-controlled, flexible-dose, two-way crossover study was conducted at four centres in the UK in 44 men with mild to moderate erectile dysfunction of no clinically obvious organic cause. The study included two 28-day treatment periods, during which time sildenafil or placebo (25–75 mg, based on efficacy) was taken as required.ResultsCompared with placebo, sildenafil was associated with increases in frequency of use, erections adequate for sexual intercourse and level of sexual satisfaction (P < 0.0001). More patients receiving sildenafil stated they would use the treatment again compared with those receiving placebo (P < 0.0001). There were no discontinuations due to sildenafil treatment.ConclusionsSildenafil is effective and well tolerated in men with mild to moderate erectile dysfunction of no clinically identifiable organic cause.

Sign in / Sign up

Export Citation Format

Share Document